Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001650664-26-000038
Filing Date
2026-04-28
Accepted
2026-04-28 16:36:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a-editasmedicineincp.htm DEFA14A 10401
2 noticeback.jpg GRAPHIC 141968
3 noticefront.jpg GRAPHIC 205718
  Complete submission text file 0001650664-26-000038.txt   490355
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37687 | Film No.: 26908523
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)